医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

A Smart Chemical Company Ventex Launches GN MEDI Antibacterial Spray Which Sterilizes 99.99 Percent of Influenza A Virus

2020年03月13日 PM11:00
このエントリーをはてなブックマークに追加


 

SEOUL, South Korea

Ventex launched GN MEDI 99.9% antibacterial spray which is an eco-friendly and odorless product containing harmless minerals for sterilization and disinfection.

Ventex is a technical company in Korea that received IR52 Jang Young-shil Awards hosted by MSIT five times. Ventex received the awards in 2019, thanks to the antibacterial spray that featured the world’s first ‘coating technique with antibacterial mineral’.

GN MEDI 99.9% antibacterial spray eliminates 99.9 percent of pneumococcus, colon bacillus, and staphylococcus aureus. And Korea Testing & Research Institute checked that it sterilized 99.99 percent of Influenza A virus that is the same RNA virus family as COVID-19.

Nationally Authorized Testing- Inspection and Research Institute, KOTITI checked that the masks’ filters worked fine after spraying the antibacterial spray on KF94 mask. They checked filters’ functions under criteria, passing amount of paraffin oil per minute following the test method of KF masks and it was widely known that KF94 mask usually prevented ninety-four percent.

When KOTITI tested pneumococcus after seventy-two hours from spraying the antibacterial spray on the mask, the mask had maintained 99.9 percent of excellent antibacterial function. The spray also eliminates the offensive smell by degrading odor.

Gyeongchan Go, President of Ventex said, “GN MEDI 99.9% antibacterial spray maintains the antibacterial effect for a long time compared to highly volatile ethanol and has an excellent safety unlike chlorine-releasing products causing cancers. Now you can use our spray that passed the skin irritation test for clothing and textile products as well as doorknobs, hand straps on the metro, and elevator buttons.”

The antibacterial spray is also used for sterilization, disinfection, and deodorization and acknowledged by KATRI that they fit for a stability standard of risk-concerned products. The safety test result will come out from U.S. Food and Drug Administration (FDA) during this month.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200313005158/en/

CONTACT

Ventex

Boram Jung

+82-70-4827-4877

bbo0026@gncos.co.kr

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 武田和Frazier Healthcare Partners宣布合作成立HilleVax, Inc.以开发临床阶段诺如病毒候选疫苗
  • Astellas and Minovia Therapeutics Announce Strategic Collaboration for Novel Mitochondrial Cell Therapy Programs
  • Sports & Health ShopeeMall & LazMall Store, Crazybadman Extends Discounts Indefinitely to Help Combat Surge in Covid-19 Cases
  • 武田薬品工業: 2021年度第1四半期は堅調な業績を達成、トップライン成長およびパイプラインの持続的な推進を加速
  • Takeda Delivers Solid First Quarter FY2021 Results, Positioning Company to Accelerate Topline Growth and Continued Pipeline Progress